Q3 2022

Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001493152-22-032048

Q3 2022 · 10-Q

Revenue

$41.00K

no prior Q3 2021 on file

Net Income

-$5.44K

N/M vs Q3 2021

EPS, diluted—

Operating Income-$5,440N/M

Operating Cash Flowderived$6,376N/M

Same quarter

Metric	Q3 2022	Q3 2021	Q3 2020	Q3 2019
Revenue	$41.00K	—	$0.00	$0.00
Net Income	-$5.44K	-$20.83K	-$25.64K	-$31.88K
EPS Diluted	—	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR